"the oncologist respondents may not be up as to speed on FTO as RAC shareholders are, and we didn't want to embarrass them."
Honestly, the number of physicians (including a few oncologists) I've spoken to about RAC and cancer treatment in general that have very little understanding about FTO is astounding. Hopefully that will change over the course of the next 12-18 months
Ann: Race releases cardioprotection market potential data, page-115
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.90 |
Change
0.115(6.44%) |
Mkt cap ! $323.5M | |||
| Open | High | Low | Value | Volume |
| $1.84 | $1.95 | $1.82 | $1.071M | 572.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10605 | $1.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 4999 | 1 |
View Market Depth
| Last trade - 16.10pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.89 |
Change
0.115 ( 9.37 %) |
||||
| Open | High | Low | Volume | ||
| $1.85 | $1.94 | $1.82 | 55841 | ||
| Last updated 15.58pm 11/06/2024 ? | |||||
| RAC (ASX) Chart |